| |
After 52 Weeks, Pitavastatin is Superior to
Pravastatin for LDL-C Lowering in Patients with HIV
|
| |
| |
Reported by Jules Levin
Late Breaker Poster presented at the CROI 2014 Conference on Retroviruses and Opportunistic Infections, March 3-6, 2014, Boston, MA, USA.
Craig A. Sponseller1, Vladimir A. Kryzhanovski2 , Roger E. Morgan3, Stuart E. Campbell3, Melanie A. Thompson4, Judith A. Aberg5
1Kowa Pharmaceuticals America, Inc., Montgomery, AL; 2Eli Lilly and Company, Indianapolis, IN; 3Kowa Research Institute, Inc., Morrisville, NC; 4AIDS Research Consortium of Atlanta, GA; 5ICAHN School of Medicine at Mount Sinai, New York, NY
Research sponsored by Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company.
|
|
| |
| |
|
|
|
